Search
for
Sort by
Research 811–840 of 1000+
- Cutaneous Manifestations of Endocrine Diseases
- Cutaneous thrombosis and ANCA-positive vasculitis associated with propylthiouracil therapy
- Histochemical studies on cutaneous stem cells in human fetal skin
- Cutaneous neuroimmunology – lessons from the hair follicle
- Cutaneous Drug Reaction Case Reports
- Cytokeratin 19 expression in usual cutaneous carcinomas
- Cutaneous mycoses in the elderly
- Cutaneous manifestations of systemic infection in children
- Cutaneous Fungus Infections in Children
- Cutaneous signals of immune system disease
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis
- Investigation on the Effect of 7% Chamomile Extract on Cutaneous Side Effects of Minoxidil in Treatment of Male Androgenetic Alopecia
- Investigation on the Effect of 7% Chamomile Extract on Cutaneous Side Effects of Minoxidil in Treatment of Male Androgenetic Alopecia
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Severe cutaneous adverse reactions to drugs
- The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience
- Adverse cutaneous reactions to soft tissue fillers – a review of the histological features
- The Cutaneous Inflammatory Response to Thermal Burn Injury in a Murine Model
- Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse Cutaneous Reactions to Antidepressants
- Subacute cutaneous lupus erythematosus presenting as erythroderma
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Clinical, histopathological and immunological characteristics of exfoliative cutaneous lupus erythematosus in 25 German short‐haired pointers
- Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
- Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
- Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia